Covishield, Covaxin Vaccines Work Against Alpha-Beta-Gamma-Delta Variants

The Covishield and Covaxin vaccines work against Alpha, Beta, Gamma and Delta variants of SARS-CoV-2. For the Delta variant, Covaxin is effective but antibody response is slightly reduced.

The Covishield and Covaxin vaccines work against Alpha, Beta, Gamma and Delta variants of SARS-CoV-2, said Director General of Indian Council for Medical Research (ICMR), Balram Bhargava.

Bhargava mentioned that the reduction of neutralisation capabilities of vaccines with different variants is based on global literature, which shows that Covaxin does not change with the Alpha variant at all and so it is same as it is with the standard strain

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘For the Delta variant, Covaxin is effective but antibody response is slightly reduced to three-fold reduction.’

"Covishield reduces slightly with Alpha, by 2.5 times.

"For Covishield, it is two-fold reduction, while in Pfizer and Moderna it is seven-fold reduction," Bhargava said.

He stated that Covishield and Covaxin work against the variants of SARS-CoV-2 -- Alpha, Beta, Gamma and Delta.

Covishield, Covaxin Reduce Infection Risk in 95% Healthcare Workers
In India, COVID vaccines Covishield and Covaxin reduced the infection risk in more than 95% of healthcare workers, according to a study by Apollo Hospitals.

According to Bhargava, the Delta Plus variant has also been isolated and cultured at ICMR-NIV, and laboratory tests to check vaccine effect on Delta Plus variant.

"We should have these results in seven to 10 days as to whether the vaccine is working against the Delta Plus variant," he said.

Antibody Production More With Covishield Compared to Covaxin
Study by Indian doctors says that both Covaxin & Covishield are effective, but, Covishield shows ‘significantly higher’ seropositivity rate & anti-spike antibody titre.

Bhargava also said that the second wave of Covid-19 is not yet over and pointed out that it is possible to avert the third wave provided individuals and society follow Covid appropriate behaviours.

He suggested that people must avoid mass gathering, use masks correctly and consistently, and any indicative hotspots need to be immediately identified.

Two Year Old Gets Covaxin Trial Vaccine Shot in UP
Five children, including three girls and two boys, who were in the age group of 2-6 years were given the Covid vaccine in Kanpur Dehat during the ongoing trial of Bharat Biotech's Covaxin on children.

Source-IANS